SMILESTONES
Milestones
2023
- Industry Outlook names Sami-Sabinsa Group as one of the "Top 10 Food Ingredient & Additive Manufacturers" for 2023
- Sabinsa Celebrates 35th Anniversary
- Sabinsa Opens Office in France, Appoints Ms. Nathalie Allaume as Sales Manager
- Sabinsa Nanjing wins '2023 Technology Innovation Award' for LactoSpore®
- Sabinsa Corporation honored with "Varro E. Tyler Commercial Investment in Phytomedicinal Research" Award
- Sami-Sabinsa Group Commits to Clean, Renewable Energy
- Sabinsa Reaches Intellectual Property Milestone with Over 400 Granted Patents
2022
- Sami-Sabinsa Group Releases Book on “Selenium in Health and Diseases”
- Sami-Sabinsa honoured with "Best Manufacturer Export Award 2022" by FKCCI
- Sami-Sabinsa Group has been ranked as one of the Top 10 Pharma Laboratories in the year 2022 by India Pharma Outlook
- Dr. Muhammed Majeed, Chairman and Founder of Sami-Sabinsa Group, was named the “Legend of the Millennium in Nutraceutical Industry” by ASSOCHAM for his outstanding contributions to the field of nutraceuticals.
- In conjunction with the Global Ayush Investment & Innovation Summit 2022, Sami-Sabinsa signed a MoU with the farmers of J&K through the J&K Medicinal Plants Board.
- Sami-Sabinsa Group signed a historic MoU with Manav Sadhan Vikas Sanstha (MSVS) for the cultivation of Garcinia indica plant used for the production of Livinol®.
- Sami-Sabinsa Group attended the Joint Parliamentary Committee meeting on the Biological Diversity (Amendment) Bill, 2021 to discuss the impact of the amendment on the Nutraceutical Industry and possible ways forward.
- Sabinsa has received Novel Food approval from the European Food Safety Authority (EFSA) for its patented Curcumin C3 Reduct®.
- Sabinsa receives TGA Approval for use of LactoSpore® as listed medicine in Australia.
- Sami-Sabinsa accomplishes Intellectual Property Milestone with over 400 plus Granted Patents (as of Dec 2022)
- Sabinsa’s Cirpusins® shows effective management of obesity and lipid levels in a published study.
- Indian Customs grants Sami-Sabinsa Group the Authorized Economic Operator (AEO) Tier–Two Certificate.
- To support various CSR initiatives, Dr. Majeed Foundation contributed Rs. 4.88 Crores during the Financial Year 2021-2022.
2021
- Sabinsa to Showcase New Products, Host Event at Vitafoods Europe
- Sabinsa’s Postbiotic LactoSporin® Wins 1st Place in NIE Awards
- Sabinsa Reaches Intellectual Property Milestone with over 300 Patents Granted
- Sabinsa Cosmeceutical Ingredients COSMOS Approved: Cococin™, Saberry®, and Nigellin® Amber
- Research Published on Sami-Sabinsa's Curcumin C3 Complex® / BioPerine® Combination as Adjuvant Therapy in COVID-19 Patients
- Court Orders Prakruti to Pay over $1 Million in Fees and Costs to Sabinsa as a Sanction for Discovery Abuses in Litigation
- Sabinsa Founder Dr. Muhammed Majeed Named Father of Indian Nutraceuticals Industry by ASSOCHAM
- New Research Published on Sabinsa’s Curcumin C3 Reduct® Supports Efficacy as an Oral Care Ingredient
- Sabinsa Top Scientist Gives Presentation to U.S. FDA
2020
- Sabinsa Expands IP Portfolio with Five New U.S. Patents, Two CII Awards for IP Portfolio, and Dr. Majeed Honored by IASTAM
- Sabinsa’s Macumax® Formula Demonstrates Vision Health Benefits in Published Study
- Sabinsa Founder Honored by ASSOCHAM for Lifetime Achievement
- Sabinsa Founder Dr. Muhammed Majeed Publishes Fourth Book on Boswellia
- Sabinsa Continues the Fight Against Adulterated Vitamin C in Food and Beverage Products by Alerting Regulatory Agencies
- Sabinsa Providing Glyphosate Test Results with Ingredients
- Sabinsa Granted Patent in Mexico on Boswellin® PS for Inflammation
- Sabinsa Granted Three New Patents in Canada, Including uC3 Clear® Water Soluble Curcumin
- Dr. Majeed Foundation Distributes 5,500 Rice Bags to Needy Communities in Karnataka, India
- Sabinsa Granted Patent on a Combination of the Company’s Ingredients for Hair Growth in Mexico
- Sabinsa Publishes Study Evaluating Hair Health Serum in Trial of Adults Hair Thinning and Loss
- Research on Sabinsa’s Cosmeceutical LactoSporin® Showing Anti-Acne Benefits Among the First Published Human Clinical Studies Examining a Probiotic Metabolite
- Sabinsa Issues Cease & Desist Letter Regarding Mischaracterized Amla Extracts to Applied Food Sciences
- Sabinsa Introduces LivLonga®, a New Patented Combination for Liver Support
- Sabinsa Earns Non-GMO Project Verification for Eleven Key Ingredients
- Sabinsa’s Curcumin C3 Complex® with BioPerine® Shown to Improve Cytokine Level
- Dr. Majeed Foundation Makes Significant Contributions to Combat COVID-19 in India, Including $1.32 Million to PM CARES Fund
- Sabinsa Warns Industry Against Mischaracterized Amla Extracts
- Research Review of Curcumin’s Immune Benefits by Sabinsa Founder Dr. Muhammed Majeed Published
- Sabinsa's pTeroWhite® Subject of Two New Published Studies Reporting Anti-Aging, Skin Brightening, and SPF Benefits
- Sami-Sabinsa Group Celebrates Three Prestigious Awards From ASSOCHAM
- Sabinsa to Feature Dispersible Curcumin and Functional GRAS Ingredients at Expo West
- Sabinsa’s Parent Company Sami Labs Breaks Ground on $30 Million USD State-of-the-Art Production Facility in India
2019
- Sabinsa Named a Top New Jersey Company for Its Dynamic Growth
- Sabinsa Issued New U.S. Patent for LactoSpore® Based upon Published Research Confirming Ability to Reverse Depression Symptoms in Patients Suffering from IBS
- Sabinsa’s Pterostilbene in Silbinol® Subject of Published Study
- Sabinsa’s Parent Dubbed Most Trusted Nutraceutical Company
- Government of Karnataka State, India Recognizes the Sami- Sabinsa Group with Three Awards for Export Excellence
- Research Finds Sabinsa’s Curcumin C3 Complex® in Combination with BioPerine® Effective for Non-Alcoholic Fatty Liver Disease
- Sami-Sabinsa Honored with Multiple “BEST of” Awards in New Delhi and Singapore
- Sabinsa Founder Dr. Muhammed Majeed Publishes Book on Reductive Metabolites of Curcuminoids
- Sabinsa to Feature Tinofolin® Nootropic, Livinol™ for Liver Health & Weight Control, and Starmeric™ Turmeric-Derived Prebiotic at Supplyside West
- Pilot Study Published Examining Curcumin C3 Complex® and BioPerine® With Taurine as Treatment for Hepatocellular Carcinoma
- Study Shows Inhibitory Effect of Curcumin Curcumin C3 Complex® and BioPerine® Combination on Malignant Mesothelioma Cells
- Sabinsa Opens Sales Office in Poland to Serve Eastern Europe
- Sabinsa’s Four Indian Manufacturing Sites Achieve FSSC 22000 Certification
- New Research Expands upon Use of Sabinsa’s Curcumin C3 Complex® as an Adjunct to Chemotherapy
- Sabinsa’s Curcumin C3 Reduct® Self-Affirmed GRAS
- Sabinsa Achieves USP GMP Audited Status for Three Additional Sites
- Published Study Reaffirms Function and Survival of Sabinsa’s LactoSpore®
- Sabinsa Shagandha™ Ashwagandha Root Extract 2.5% Designed to Meet USP Monograph, Verified by Prominent Botanical Testing Expert Alkemist Labs
- Sabinsa Scientist Dr. Natarajan honored by IASTAM for Nutraceutical Product Development
- Sabinsa Launches LactoSporin®: Novel Probiotic Metabolite For Skin and Hair
- Sabinsa Awarded New Patents for ForsLean®: New Scientific Discoveries Warrant Energy Balance Claims
- Sabinsa’s Biotechnology Site Achieves USP GMP Audited Status
- Sabinsa’s Manufacturing Arm Receives Research Funding From The Government of India
- Published Analysis of Curcumin Research Provides Comprehensive Overview
2018
- Sami–Sabinsa Founder and Sami Labs Honored With Multiple Awards by Associated Chambers of Commerce & Industry of India for Outstanding Nutraceuticals Industry Achievement
- Research on Curcumin’s Positive Effects on Microbiome Published Sabinsa Supplied Curcumin C3 Complex® and BioPerine® to Researchers
- Sami-Sabinsa Group Diversifies into Information Technology and Business Solutions With Expansion of Edkal Technologies to US
- Sami-Sabinsa Honored By Pharmexcil For Export Excellence
- Sabinsa’s Shelf Stable Probiotic LactoSpore® May Improve Cholesterol Levels, Study Suggests
- Sami–Sabinsa Honored by Associated Chambers of Commerce & Industry of India for Beauty, Wellness & Personal Care
- Sabinsa’s Nigellin™ Black Cumin Seed Extract Identified as a Potent Favorable Immunomodulation in Asthma Inflammation
- Sabinsa Signs Memorandum of Understanding with Japan External Trade Organization at Summit With Prime Ministers of India and Japan
- Sabinsa Opens Toronto Office to Support Canadian Customers and Market
- Sami-Sabinsa Group FSMA Implementation Update: 14 Staff PCQI Certified
- Sabinsa Honored with Two Prestigious Awards Acknowledging the Significance of the Company’s Cultivation and Reforestation Programs
- Sami-Sabinsa Group Scientists Publish Research on Flow Cytometry as an Effective Test Method to Assess Viable Spore Count in LactoSpore®
- Sami-Sabinsa Group Acquires Exclusive Global Marketing Rights for European and USA Patents on Oroxylum indicum
- Sami-Sabinsa’s Pterocarpus Marsupium Reforestation Program Named Industry Initiative of The Year Award Finalist
- Sami-Sabinsa Recognized For Export Achievement by Federation of Karnataka Chambers of Commerce & Industry
- Sabinsa’s Legal Victory Over Olive Lifesciences for Patent Infringement Profiled in Prominent Law Journal
- Sami Labs - Sabinsa Hyderabad Facility Receives NSF GMP Certification
- Sabinsa Founder Dr. Muhammed Majeed Named NutraChampion
- Sabinsa parent company Sami Labs honored with outstanding export award
- Sabinsa successfully protects its Curcumin C3 Reduct® technology
- Tufts - Tohoku study on curcumin + piperine combination verifies Sabinsa’s research on synergistic properties
- Sabinsa announces 10 year reforestation commitment to Pterocarpus marsupium cultivation
- Sabinsa and Eurofins enter into global ID testing agreement for proprietary ingredient
2017
- New patents granted to Sabinsa’s cosmetics division in US And EU
- Sabinsa granted US patent for synbiotic composition of LactoSpore® shelf stable probiotic and cranberry fibers
- Sabinsa publishes scientific compendium on BioPerine® black pepper extract
- Shaheen Majeed named Sabinsa President worldwide
- Sabinsa successfully protects its Curcumin C3 Reduct® technology
- Sabinsa’s Curcumin C3 Complex® with BioPerine® shows protective role in lipid profile modification in type 2 diabetes in published study
- Court orders Olive Lifesciences to pay Sabinsa $2.2 Million for willfull infringement
- Sabinsa granted US Patent on LactoSpore® for IBS
- Sabinsa’s Curcumin C3 Complex® studied for antioxidant effect In diabetes patients
- Sabinsa's DigeZyme® shows benefit for delayed onset muscle soreness in published study
2016
- Sabinsa’s Boswellin® super reported in Japanese study to show improvement in knee pain
- European journal publishes article on Sami / Sabinsa oil control moisturizer safety and efficacy
- Nachurel ingredients agrees to consent judgment honoring Sabinsa’s Tetrahydrocurcuminoids patent
- Sabinsa’s Curcumin C3 Complex® in combination with Omega-3S found to have synergistic effect
- Sabinsa again honored with two pharmexcil awards noting excellence in patents and exports
- Sabinsa receives approval for new health claims on Curcumin C3 Complex® and Curcumin C3 reduct® in Canada
- Sabinsa successfully defended its proprietary rights for “Boswellin”
- Sabinsa achieves significant canadian health claim on IBS for shelf-stable probiotic LactoSpore®
- Sami-Sabinsa recognized by global health & pharma as the best international life science company and most innovative inflammatory condition treatment
- Sabinsa’s parent company Sami Labs recognized for excellence in research and development
- Sabinsa / Sami Labs recognized for export excellence by Karnataka government trade promotion center
- New safety, stability and efficacy studies published on Sabinsa’s GRAS, shelf-stable probiotic LactoSpore®
- Sabinsa defends Tetrahydrocurcuminoids patent with legal action
- A clinical study by the university of georgia found that Resveratrol fortified with Sabinsa’s BioPerine® increases mitochondrial function
- Sabinsa announces curcumin testing program to assure authenticity in campaign to eliminate adulteration with synthetics
- Metabolic syndrome study on Sabinsa’s Curcumin C3 Complex® honored with university research of the year award
- Sabinsa receives "no questions” letter from the us FDA on GRAS status for LactoSpore®
- Muhammed Majeed, Ph.D. honored as industry legend and inducted into the Hall of Legends at Natural Products Expo West, 2016
- Dr. Majeed, Sabinsa’s founder, honored with Global Innovation & Excellence Award for 110 patents, and recently added 15 new patents
- Stability research published on Sabinsa's LactoSpore® shelf stable probiotic for functional foods
- Cumulative safety data of ForsLean®, the company’s patented coleus forskohlii extract, published in an International Scientific Journal
2015
- Sabinsa’s LactoSpore® human safety study cleared for health Canada access
- Sabinsa patent infringement litigation against prakruti settled: Curcumin C3 Complex® patent successfully defended
- Sabinsa launches new, nano-free water soluble curcumin form: Uc3 clear™
- Sami Labs recognized with two state export excellence awards by visvesvaraya trade promotion centre, Karnataka, India
- Sabinsa once more successfully protects Curcumin C3 Complex® patent infringement litigation against herbakraft settled
- Sabinsa awarded four new US patents: patent portfolio total climbs to 95
- Sabinsa expands herb cultivation program founder promotes sustainability, advocates cultivation to protect India’s herbal legacy
- Sabinsa’s Curcumin C3 Complex® shows significant benefits in lipid levels in patients with coronary artery disease
- UK study shows Sabinsa’s Curcumin C3 Complex® to be safe adjunct to, and enhance efficacy of, folfox chemotherapy
- Sabinsa / Sami Labs recognized with award for export excellence by Karnataka chamber of commerce
- Sabinsa’s Utah facility receives foreign site registration number from Canada
- Shaheen Majeed appointed to Sami Labs group board of directors
- Sabinsa again honored with two pharmexcil awards noting excellence in patents and exports
- Curry Powder To Clinical Significance: New book provides a comprehensive understanding of curcumin & studies on Curcumin C3 Complex®
- Sabinsa victorious in litigation against nutribiolink for Curcumin C3 Complex® patent infringement
2014
- Sabinsa adds four new patents, bringing world wide portfolio to 91
- C3 Reduct® wins Functional Ingredients editors choice award for best science
- Sami and Sabinsa receive Best New Product Excellence Award in the raw material category at Panacea-Natural roduct Expo India for Saberry®
- Sabinsa / Sami Labs entered into a Memorandum of Understanding with India’s Ayurvedic research organization, Arya Vaidya Sala, Kottakkal (AVS)
- Sabinsa / Sami Labs receives two pharmexcil awards for 2012 – 2013 in the herbals, ayurveda & nutraceuticals category: The gold award for patents and the silver award for exports in herbals
- Former President of India visits Sami Labs (late A.P.J. Abdul Kalam)
- Sabinsa introduces new form of coleus with ForsLean® Soft Extract
- Study shows Boswellia® cream may provide relief for psoriasis
- Sabinsa initiates lawsuit against four companies for Curcumin C3 Complex® patent infringement
- Iranian clinical study shows combination of C3 Complex® and BioPerine® offer relief for osteoarthritis patients
- Sabinsa launches animal nutrition division: VetVitals®
- Sabinsa’s C3 Complex® shown in study to benefit metabolic syndrome
- Sabinsa/Sami Labs acquires KCP Biotech, expands capacity and adds more colors
- Sabinsa teams up with Fruit D’Or to launch LactoSpore®-Cranberry combination LactoCran™
- Sabinsa’s LactoSpore® moves into cosmeceuticals with topical Candida products
2013
- Next generation of curcumin launched, resolving potency, color, dosage, stability and bioavailability concerns, called Curcumin C3 Reduct®
- Recipient of Frost & Sullivan’s 2013 North American Integrated Prebiotic Delivery Technology Innovation Award
- United States patent granted on a unique weight management formula
- United States patent granted for a natural preservative, SabiLize®
- Sabinsa Utah facility earns NSF Good Manufacturing Practices (GMP) registration
- Sabinsa on Wheels returns to USA, three major states selected and presented at Utah, California, and New Jersey
- Sabinsa’s Curcumin receives GRAS no comment letter from FDA
- Sabinsa's Sami Labs named product Innovator Of The Year
- Sabinsa's LactoSpore® inspires gluten-free expert to create gourmet cookies
- Sabinsa launches D'Cosmix range of dermaceutical composites at International exhibitions
- Sabinsa breaks ground on additional facility, increasing production 200%
2012
- Curcumin C3 Complex® wins Functional Ingredients editor's choice award in the marketing category
- LactoSpore® chosen for tutti frutti, world's top selling self-serve frozen yogurt
- The first non-diary use of Sabinsa’s Shelf-Stable Probiotic, LactoSpore®, can be found in Colombia’s Perman Bread
- New Study says Sabinsa's Curcumin C3 Complex® shows significant reduction in Serum Triglycerides
- Sabinsa publishes book on Tetrahydrocurcuminoids
- Sabinsa on Wheels held for the first time in Seoul, South Korea
- Sabinsa wins patent in Japan for coleus derived Glaucoma Treatment product
2011
- Sami Labs inks Research Collaboration Agreement with National Institute of Medicinal Materials (NIMM), Ministry of Health, Vietnam for Research & Development of Vietnamese Traditional Medicinal Plants
- Sabinsa introduces Integrated Nutritional Composites™
- Sabinsa's BioPerine® validated in Resveratrol pre-clinical study
- Sabinsa opens office in South Korea
- Sabinsa receives top Pharmexcil Award
- Sabinsa R&D named Best Innovation and Technology Company by FICCI
2010
- Sami's Kunigal plant near Bangalore, India received NSF (National Sanitation Foundation) GMP certification
- Received the first patent in China for "Process For Preparing Water Soluble Diterpenes And Their Applications"
- Sami Labs inks an agreement with CIPLA to market its drug, Sornip for Psoriasis in Indian market
- Sami's Kunigal plant near Bangalore, India received Bureau Veritas ISO 22000 Certification
2009
- Sabinsa received the 2009 Herbal Industry Leader Award from the American Herbal Products Association
- Sabinsa received its 57th patent and it is the first patent from Russia
2008
- NABL accreditation for laboratories of Sami Labs Limited
- Continuous Extraction plant commissioned by Sami Labs Limited in Bangalore
2007
- Sabinsa sets up its office in South Africa
2006
- Forskolin Eye Drops approved by DCGI for Glaucoma
- Sabinsa Europe GmBH was set up in Langen, near Frankfurt in Germany
2005
- Received two patents for Tetrahydropiperine
- Received the second Thomas Alva Edison Patent Award for 2005
2004
- Sabinsa's US Patent for ForsLean® received the Thomas Alva Edison Patent Award for 2004
- Dr. Majeed was conferred the Ellis Island Medal of Honor by the National Ethnic Coalition of Organizations (NECO)
2003
- MGP Herbal (P) Ltd was acquired to facilitate and co-ordinate Herbal Cultivation - a major step that helped provide jobs to several farmers in India
2002
- Super-Critical Fluid Extraction facility set up at Nelamangala
- The R & D Centre of Sami Labs Limited, Bangalore received the DSIR Award for its R & D efforts
2001
- The anti-obesity product Forslean® was voted as the Best New Product of the year by Nutraceutical Industry Association – Nutracon in the US
- Sabinsa received its first European patent on Curcuminoids
- Sabinsa Japan Corporation was started
2000
- Biotechnology Center established at Nelamangala, Bangalore
- Tetrahydrocurcuminoids, also referred to as “White Curcumin” was introduced as a skin lightener into the US market
1998
- Sami Chemicals and Extract Pvt. Ltd. – name was changed to Sami Labs Limited to reflect more accurately its current activities
1997
- New Jersey Technology Fast 50 Award
- Sabinsa listed again in the Inc 500 companies, ranking # 90
- Award for Export Performance for Spice products from President of India
1996
- Sabinsa was listed in the Inc 500 companies, ranking # 70
- First US patent awarded for the product BioPerine® was awarded to Sabinsa Corporation
- An Export-Oriented manufacturing unit is established at Kunigal, Bangalore
1993 - 95
- Standardization of Indian herbal medicines by Sami research group
- Sabinsa started the “Sabinsa on Wheels” program also know as SOW. Here the Sabinsa team endeavors to share its knowledge to a large group of professionals and common man on its diverse range of products
1991
- Sami Chemicals and Extracts Pvt Ltd set up in Bangalore
1988
- Sabinsa Corporation, New Jersey USA was setup
